Acute hyperglycemia is common in critically ill patients. Strict control of blood glucose (BG) concentration has been considered important because hyperglycemia is associated independently with increased intensive care unit mortality. After intensive insulin therapy was reported to reduce mortality in selected surgical critically ill patients, lowering of BG levels was recommended as a means of improving patient outcomes. However, a large multicenter multination study has found that intensive insulin therapy increased mortality significantly. A difference in variability of BG control may be one possible explanation why the effect of intensive insulin therapy varied from beneficial to harmful. Several studies have confirmed significant associations between variability of BG levels and patient outcomes. Decreasing the variability of the BG concentration may be an important dimension of glucose management. If reducing swings in the BG concentration is a major biologic mechanism behind the putative benefits of glucose control, it may not be necessary to pursue lower glucose levels with their attendant risk of hypoglycemia.
WolfeRRAllsopJRBurkeJF. Glucose metabolism in man: responses to intravenous glucose infusion. Metabolism.1979;28 (3): 210–20.
2.
ShangrawREJahoorFMiyoshiHNeffWAStuartCAHerndonDNWolfeRR. Differentiation between septic and postburn insulin resistance. Metabolism.1989;38 (10): 983–9.
3.
CelyCMAroraPQuartinAAKettDHScheinRM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest.2004;126 (3): 879–87.
4.
McCowenKCMalhotraABistrianBR. Stress-induced hyperglycemia. Crit Care Clin.2001;17 (1): 107–24.
5.
Van den BergheGWoutersPWeekersFVerwaestCBruyninckxFSchetzMVlasselaersDFerdinandePLauwersPBouillonR. Intensive insulin therapy in the critically ill patients. N Engl J Med.2001;345 (19): 1359–67.
6.
MizockBA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med.1995;98 (1): 75–84.
RobinsonLEvan SoerenMH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues.2004;15: 45–62.
9.
GearhartMMParbhooSK. Hyperglycemia in the critically ill patient. AACN Clin Issues.2006;17: 50–5.
10.
BurkettEKeijzersGLindJ. The relationship between blood glucose level and QTc duration in the critically ill. Crit Care Resusc.2009;11 (1): 8–13.
11.
MitchellIKnightEGissaneJTamhaneRKolliRLeditschkeIABellomoRFinferS; Australian and New Zealand Intensive Care Society Clinical Trials Group. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Crit Care Resusc.8 (4): 289–93.
12.
CoursinDBConneryLEKetzlerJT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med.2004;32 (4 Suppl): S116–25.
13.
MalmbergKRydenLEfendicSHerlitzJNicolPWaldenstromAWedelHWelinL. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol.1995;26 (1): 57–65.
14.
MalmbergK. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ.1997;314 (7093): 1512–5.
15.
OrfordNStowPGreenDCorkeC. Safety and feasibility of an insulin adjustment protocol to maintain blood glucose concentrations within a narrow range in critically ill patients in an Australian level III adult intensive care unit. Crit Care Resusc.2004;6 (2): 92–8.
16.
OrfordNR. Intensive insulin therapy in septic shock. Crit Care Resusc.2006;8 (3): 230–4.
17.
Van den BergheGWilmerAHermansGMeerssemanWWoutersPJMilantsIVan WijngaerdenEBobbaersHBouillonR. Intensive insulin therapy in the medical ICU. N Engl J Med.2006;354 (5): 449–61.
18.
Van den BergheGWoutersPJBouillonRWeekersFVerwaestCSchetzMVlasselaersDFerdinandePLauwersP. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med.2003;31 (2): 359–66.
19.
DellingerRPCarle:JMMasurHGerlachHCalandraTCohenJGea-BanaclocheJKehDMarshallJCParkerMMRamsayGZimmermanJLVincentJLLevyMM; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med.32 (3): 858–73.
20.
DellingerRPLevyMMCarletJMBionJParkerMMJaeschkeRReinhartKAngusDCBrun-BuissonCBealeRCalandraTDhainautJFGerlachHHarveyMMariniJJMarshallJRanieriMRamsayGSevranskyJThompsonBTTownsendSVenderJSZimmermanJLVincentJL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med.2008;34 (1): 17–60.
21.
BrunkhorstFMEngelCBloosFMeier-HellmannARagallerMWeilerNMoererOGruendlingMOppertMGrondSOlthoffDJaschinskiUJohnSRossaintRWelteTSchaeferMKernPKuhntEKiehntopfMHartogCNatansonCLoefflerMReinhartK; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med.358 (2): 125–39.
22.
23.
NICE-SUGAR Study Investigators, FinferSChittockDRSuSYBlairDFosterDDhingraVBellomoRCookDDodekPHendersonWRHébertPCHeritierSHeylandDKMcArthurCMcDonaldEMitchellIMyburghJANortonRPotterJRobinsonBGRoncoJJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009;360 (13): 1283–97.
24.
GriesdaleDEde SouzaRJvan DamRMHeylandDKCookDJMalhotraADhaliwalRHendersonWRChittockDRFinferSTalmorD. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ.2009;180 (8): 821–7.
25.
WienerRSWienerDCLarsonRJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA.2008;300 (8): 933–44.
26.
EgiMMorimatsuHTodaYMatsusakiTSuzukiSShimizuKIwasakiTTakeuchiMBellomoRMoritaK. Hyperglycemia and the outcome of pediatric cardiac surgery patients requiring peritoneal dialysis. Int J Artif Organs.2008;31 (4): 309–16.
27.
EgiMBellomoRStachowskiEFrenchCJHartGStowPLiWBatesS. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. Am J Respir Crit Care Med.2006;173 (4): 407–13.
28.
EgiMBellomoRStachowskiEFrenchCJHartGStowP. Circadian rhythm of blood glucose values in critically ill patients. Crit Care Med.2007;35 (2): 416–21.
29.
AliNAO'BrienJMJrDunganKPhillipsGMarshCBLemeshowSConnorsAFJrPreiserJC. Glucose variability and mortality in patients with sepsis. Crit Care Med.2008;36 (8): 2316–21.
30.
HirshbergELarsenGVan DukerH. Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med.2008;9 (4): 361–6.
31.
DossettLACaoHMoweryNTDortchMJMorrisJMJrMayAK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg.2008;74 (8): 679–85; discussion 685.
32.
WaeschleRMMoererOHilgersRHerrmannPNeumannPQuintelM. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit Care.2008;12 (5): R129.
33.
KrinsleyJS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med.2008;36 (11): 3008–13.
34.
QuagliaroLPiconiLAssaloniRMartinelliLMotzECerielloA. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes.2003;52 (11): 2795–804.
35.
MonnierLMasEGinetCMichelFVillonLCristolJPColetteC. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA.2006;295 (14): 1681–7.
36.
BrownleeM. Biochemistry and molecular cell biology of diabetic complications. Nature.2001;414 (6865): 813–20.
37.
BrownleeM. The pathobiology of diabetic complications: a unifying mechanism. Diabetes.2005;54 (6): 1615–25.
38.
WatadaHAzumaKKawamoriR. Glucose fluctuation on the progression of diabetic macroangiopathy—new findings from monocyte adhesion to endothelial cells. Diabetes Res Clin Pract.2007;77Suppl 1: S58–61.
39.
AzumaKKawamoriRToyofukuYKitaharaYSatoFShimizuTMiuraKMineTTanakaYMitsumataMWatadaH. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol.2006;26 (10): 2275–80.
40.
RissoAMercuriFQuagliaroLDamanteGCerielloA. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab.2001;281 (5): E924–30.
41.
YamashitaKOkabayashiTYokoyamaTYatabeTMaedaHManabeMHanazakiK. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg.2008;106 (1): 160–3, table of contents.
42.
BellomoREgiM. What is a NICE-SUGAR for patients in the intensive care unit?. Mayo Clin Proc.2009;84 (5): 400–2.
